Terms ending in 2034
Every in-force patent on Cathay Biotech Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,647,976 | Expression of Polypeptides Involved in Lysine Decarboxylation, and Methods and Applications Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 10,400,257 | Expression of Recombinant Tetracycline Efflux Pumps for the Production of Lysine or Lysine-Derived Products, and Methods and Applications Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 11,098,329 | Expression of Recombinant Tetracycline Efflux Pumps for the Production of Lysine or Lysine-Derived Products, and Methods and Applications Thereof In force · High confidence | Cibt America Inc. | In force | High confidence | |
| US 10,487,176 | Nylon Salt and Preparation Method Therefor In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 11,008,279 | Method for Purifying 1,5-Pentanediamine and the 1,5-Pentanediamine Prepared Thereby In force · High confidence | CIBTAmerica Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Cathay Biotech Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.